Correlation Between Faron Pharmaceuticals and Segro Plc

Can any of the company-specific risk be diversified away by investing in both Faron Pharmaceuticals and Segro Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Faron Pharmaceuticals and Segro Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Faron Pharmaceuticals Oy and Segro Plc, you can compare the effects of market volatilities on Faron Pharmaceuticals and Segro Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Faron Pharmaceuticals with a short position of Segro Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Faron Pharmaceuticals and Segro Plc.

Diversification Opportunities for Faron Pharmaceuticals and Segro Plc

0.83

Correlation Coefficient

Faron Pharmaceuticals  Segro Plc

Very poor diversification

The 3 months correlation between Faron and Segro is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Faron Pharmaceuticals Oy and Segro Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Segro Plc and Faron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Faron Pharmaceuticals Oy are associated (or correlated) with Segro Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Segro Plc has no effect on the direction of Faron Pharmaceuticals i.e., Faron Pharmaceuticals and Segro Plc go up and down completely randomly.

Pair Corralation between Faron Pharmaceuticals and Segro Plc

Assuming the 90 days trading horizon Faron Pharmaceuticals Oy is expected to under-perform the Segro Plc. In addition to that, Faron Pharmaceuticals is 3.07 times more volatile than Segro Plc. It trades about -0.1 of its total potential returns per unit of risk. Segro Plc is currently generating about -0.29 per unit of volatility. If you would invest  90,440  in Segro Plc on September 16, 2024 and sell it today you would lose (19,040) from holding Segro Plc or give up 21.05% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Faron Pharmaceuticals Oy  vs.  Segro Plc

Faron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Faron Pharmaceuticals Oy has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Segro Plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Segro Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Faron Pharmaceuticals and Segro Plc

The main advantage of trading using opposite Faron Pharmaceuticals and Segro Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Faron Pharmaceuticals position performs unexpectedly, Segro Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Segro Plc will offset losses from the drop in Segro Plc's long position.

The idea behind Faron Pharmaceuticals Oy and Segro Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.